Koichi Tsuneyama is an expert in Hepatology at Tokushima University (Japan). As of October 2026, ScienceLeadR ranks Koichi Tsuneyama in the top 1% of experts worldwide for Cholestasis, Bile Duct Diseases and Biliary Tract Diseases. Koichi Tsuneyama has authored 523 publications, the most recent in 2026. SLR score: 1,277 (community average: 125). How the SLR is computed.

LeadR Profile

Koichi Tsuneyama Tokushima University Japan
1 277 ScienceLeadR Reputation 1277
Network Map

Hepatology

Subspecialties: Gastroenterology - Biochemistry - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1994 - 2026

Source: PubMed

Kanazawa University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 523

Citations

Citations: 19 335 1st author: 29 Last author: 65 Unique author: 3


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
CAM5.2 immunostaining visualizes hemodynamic-driven ductular-like differentiation in the liver:a practical marker for distinguishing circulatory disturbance-related hyperplastic lesions from hepatocellular tumors.
PMID 42021082 — hepatocytes, neoplasms, wounds and injuries, hemodynamics
J Med Invest20260
HDV Infection Status in Tokushima Prefecture Based on Histopathological Evaluation:A Single-Institution Study.
PMID 42021097 — carcinoma, hepatocellular, liver, carcinogenesis, viruses, prevalence, tissues, infections
J Med Invest20260
Reframing thymic epithelial tumors through single-cell transcriptomics: a narrative review.
PMID 41982618 — cells, thymoma, epithelial cells, neoplasms, classification
Mediastinum20260
Orthotopic Esophageal Cancer Xenograft Model in Immunosuppressed Microminipigs for Near-Infrared Fluorescence Endoscopy.
PMID 41934134 — injections, cells, cetuximab, neoplasms, endoscopy, esophageal neoplasms, immunosuppression therapy, heterografts
Cancer Sci20260
A Case of Ovarian Seromucinous Borderline Tumor With a Predominant Serous Component Suggesting Serous Borderline Tumor With Mucinous Differentiation.
PMID 41930595 — cells, ovary, neoplasms, pathology, classification, gynecology
Int J Gynecol Pathol20260

LeadR Networks

Main global connection map